文献速递糖尿病

2型糖尿病患者睡眠与HbA1c:哪些睡眠特征最重要?

Sleep and HbA1c in Patients With Type 2 Diabetes: Which Sleep Characteristics Matter Most?
PubMed 文献 · Diabetes Care · 2019-11-12

该研究纳入172例2型糖尿病患者,通过7天腕表活动记录和睡眠问卷评估多种睡眠特征与HbA1c的关联。结果显示睡眠时长变异性单独关联最强,其次为总睡眠时长(U形)、主观睡眠质量和睡眠中点变异性;三者组合可解释HbA1c变异的10.3%。调整协变量后总睡眠时长和主观睡眠质量关联最强,共解释6.0%。

要点

  • 睡眠时长变异性与HbA1c关联最强,β=0.239,R²=4.9%。
  • 总睡眠时长呈U形关联,主观睡眠质量和睡眠中点变异性亦相关。
  • 睡眠中点时间和主观失眠症状与HbA1c无显著关联。

核心结论

  • 睡眠总体上可能是2型糖尿病患者可干预的重要因素。
  • 预防睡眠不足可能应作为以睡眠为中心的2型糖尿病管理的首要焦点。

研究设计与样本

  • 研究纳入172例2型糖尿病患者,完成7天腕表活动记录和睡眠问卷。
  • 采用线性回归分别及联合评估睡眠特征与HbA1c的关联。

主要发现

  • 睡眠时长变异性单独关联最强:β=0.239,P=0.002,R²=4.9%。
  • 总睡眠时长呈U形关联:β=1.161/β2=1.044,P=0.017/0.032,R²=4.3%。
  • 主观睡眠质量:β=0.191,P=0.012,R²=3.6%。
  • 睡眠中点变异性:β=0.184,P=0.016,R²=3.4%;睡眠效率:β=-0.150,R²=2.3%。
  • 睡眠中点时间和主观失眠症状与HbA1c无显著关联。

关键数值与推荐

  • 睡眠时长变异性、总睡眠时长和主观睡眠质量联合解释HbA1c变异的10.3%。
  • 调整协变量后总睡眠时长和主观睡眠质量关联最强,联合解释HbA1c变异的6.0%。

临床怎么用

  • 在2型糖尿病管理中应关注睡眠时长变异性、总睡眠时长和主观睡眠质量。
  • 预防睡眠不足可作为睡眠相关管理的重点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Poor sleep has been identified as a risk factor for poor glycemic control in individuals with type 2 diabetes (T2D). As optimal sleep can be characterized in several ways, we evaluated which sleep characteristics are most strongly associated with glycated hemoglobin A1c (HbA1c). RESEARCH DESIGN AND METHODS: A total of 172 patients with T2D completed 7-day wrist-actigraphy and sleep questionnaires. Linear regression was used to evaluate associations between sleep measures (total sleep duration, variability in sleep duration, midsleep time, variability in midsleep time, sleep efficiency, subjective sleep quality, and subjective insomnia symptoms) and HbA1c, individually and in concert. RESULTS: Variability in sleep duration was individually most strongly associated with HbA1c (β = 0.239; P = 0.002; R 2 = 4.9%), followed by total sleep duration (U-shaped: β = 1.161/β2 = 1.044; P = 0.017/0.032; R 2 = 4.3%), subjective sleep quality (β = 0.191; P = 0.012; R 2 = 3.6%), variability in midsleep time (β = 0.184; P = 0.016; R 2 = 3.4%), and sleep efficiency (β = -0.150; R 2 = 2.3%). Midsleep time and subjective insomnia symptoms were not associated with HbA1c. In combination, variability in sleep duration, total sleep duration, and subjective sleep quality were significantly associated with HbA1c, together explaining 10.3% of the variance in HbA1c. Analyses adjusted for covariates provided similar results, although the strength of associations was generally decreased and showing total sleep duration and subjective sleep quality to be most strongly associated with HbA1c, together explaining 6.0% of the variance in HbA1c. CONCLUSIONS: Sleep in general may be a modifiable factor of importance for patients with T2D. The prevention of sleep curtailment may serve as a primary focus in the sleep-centered management of T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Brouwer A, van Raalte DH, Rutters F, et al. Sleep and HbA1c in Patients With Type 2 Diabetes: Which Sleep Characteristics Matter Most? Diabetes Care. 2019. PMID: 31719053. doi:10.2337/dc19-0550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。